IHC assay indicated that PIK3CA was located in the cytoplasm of bladder cancer cells (Figure 1C), and displayed that PIK3CA protein was detected in 44/56 (78.6%) bladder cancer cases and with a higher positive rate than normal cases (P = 0.002). This evidence concerns the gene PIK3CA and urinary bladder cancer.